Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
The consideration for the acquisition is US $ 2.25 million
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
It is the only biopharmaceutical company in India to offer all three dosage strengths of the drug (125mcg, 250mcg, and 500mcg)
The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Subscribe To Our Newsletter & Stay Updated
